Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
CVS Pharmacy Inc. conspired with several of the nation’s largest pharmacy middlemen to hide the lowest prices they offered for generic drugs, two union health plans say.
The allegations against CVS, its pharmacy benefit manager subsidiary Caremark Rx, and other PBMs, including Express Scripts Inc. and UnitedHealth Group Inc.’s OptumRx Inc., adequately stated federal racketeering claims, Chief Judge William E. Smith of the U.S. District Court for the District of Rhode Island said. Smith allowed the plaintiffs to add the claims to their original fraud complaint against CVS.
The claims against CVS and the PBMs are emblematic of an increasing wave of criticism aimed at retail pharmacies and PBMs over allegedly unfair drug pricing practices. In February, independent pharmacists in Arkansas complained about CVS Caremark’s reimbursement rates. The group is calling for legislation that would provide greater state oversight of all PBMs operating in the state. Iowa, Kentucky, New Mexico, New York, Texas, and West Virginia are among the states currently grappling with similar PBM reimbursement issues.
The added claims allege CVS conspired with the PBMs to hide from the health plans the lowest prices it charged individual cash-paying CVS customers for certain generic drugs. The plans allege CVS kept secret the prices it charged cash-paying customers under its now-discontinued Health Saving Pass (HSP) program so it didn’t have to offer the same discounts to them.
The plaintiffs allege in their original complaint that CVS fraudulently overcharged them by collecting more for generic drugs than it was allowed to do under the National Council for Prescription Drug Program. According to this complaint, the HSP program, which CVS developed to compete with big-box retailers such as Walmart Inc., was a key component of CVS’s fraud.
For a nominal program fee, the HSP program allowed cash-paying CVS customers to access discounted generic drug prices. But because the HSP prices weren’t made available to the general public, CVS didn’t include the HSP discounted price in the “Usual and Customary” price it reported as the lowest net cash price cash-paying customers would have paid for certain generic drugs.
The plaintiffs allege CVS teamed up with the PBMs to keep the HSP price a secret from the health plans. Smith said those allegations sufficed at this stage of the litigation.
“To be sure, Plaintiffs do not allege an explicit agreement among the PBMs to look the other way as CVS failed to report HSP prices,” Smith said. “But they do allege the PBMs communicated with each other and with CVS in order to orchestrate the alleged fraud,” he said, and that was enough to justify allowing the plans to add the racketeering claims to their complaint.
The case is Sheet Metal Workers Local Welfare & Benefit Fund v. CVS Pharmacy, Inc. , 2018 BL 113829, D.R.I., 20 C.A. No. 16-46 WES C.A. No. 16-447 WES, 3/31/18 .
To contact the reporter on this story: Dana A. Elfin in Washington at email@example.com
To contact the editor responsible for this story: Randy Kubetin at firstname.lastname@example.org
The ruling is at http://src.bna.com/xuW.
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)